In the last trading session, 1.24 million Cognition Therapeutics Inc (NASDAQ:CGTX) shares changed hands as the company’s beta touched 0.86. With the company’s per share price at $0.3 changed hands at -$0.02 or -7.55% during last session, the market valuation stood at $18.60M. CGTX’s last price was a discount, traded about -746.67% off its 52-week high of $2.54. The share price had its 52-week low at $0.22, which suggests the last value was 26.67% up since then. When we look at Cognition Therapeutics Inc’s average trading volume, we note the 10-day average is 1.16 million shares, with the 3-month average coming to 1.14 million.
Analysts gave the Cognition Therapeutics Inc (CGTX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CGTX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Cognition Therapeutics Inc (NASDAQ:CGTX) trade information
Instantly CGTX was in red as seen at the end of in last trading. With action 17.65%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -82.95%, with the 5-day performance at 17.65% in the green. However, in the 30-day time frame, Cognition Therapeutics Inc (NASDAQ:CGTX) is 23.15% up. Looking at the short shares, we see there were 1.54 million shares sold at short interest cover period of 0.98 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.44%. The 2025 estimates are for Cognition Therapeutics Inc earnings to increase by 52.62%, but the outlook for the next 5-year period is at 32.88% per year.
CGTX Dividends
Cognition Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-07.
Cognition Therapeutics Inc (NASDAQ:CGTX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.81% of Cognition Therapeutics Inc shares while 18.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 18.94%. There are 18.79% institutions holding the Cognition Therapeutics Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 2.8644% of the shares, roughly 1.15 million CGTX shares worth $1.9 million.
AWM INVESTMENT COMPANY, INC. holds the second largest percentage of outstanding shares, with 1.6224% or 0.65 million shares worth $1.08 million as of 2024-06-30.
